[Problems of differentiated thymoleptic therapy in phasic depressions].
作者信息
Smulevich A B, Vorob'ev V Iu, Zavidovskaia G I, Lobova E K, Balashova M G
出版信息
Zh Nevropatol Psikhiatr Im S S Korsakova. 1974;74(6):912-8.
PMID:4454918
Abstract
摘要
相似文献
1
[Problems of differentiated thymoleptic therapy in phasic depressions].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1974;74(6):912-8.
2
[Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].关于混合性精神病及精神分裂症症状性抑郁表现的治疗管理的思考
Osp Psichiatr. 1967 Oct-Dec;35(4):501-34.
3
[Experience in the use of a new thymoleptic (34,276-Ba) in the treatment of depressive states].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1972;72(6):925-9.
4
[Comparative study of dibencycladine (Ludiomil) and imipramine in the treatment of psychotic depression].双环苄啶（路滴美）与丙咪嗪治疗精神病性抑郁症的对比研究
Int J Clin Pharmacol. 1973 Feb;7(1):54-61.
5
[Depressive forms of schizophrenia. Trial of clomipramine treatment].
Encephale. 1971 Jul-Aug;60(4):312-34.
6
[Clinical experiences with a new thymoleptic].[一种新型抗抑郁药的临床经验]
Schweiz Arch Neurol Neurochir Psychiatr. 1967;100(1):167-78.
7
[Clinical-psychiatric observations with noxiptilin in depressive syndromes].
Arzneimittelforschung. 1969 Jun;19:Suppl 5a:905+.
8
[Use of clomipramine in psychiatry. Considerations on 4 years' experimentation].
Ann Med Psychol (Paris). 1972 May;1(5):709-14.
9
10
[Chief histocompatibility system in cyclophrenia and its relationship to lithium therapy].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1977;77(8):1199-1200.
Zotero 插件